Back to Agenda
How Common Data Models Can Address the Challenges in the Use of Clinical Trial and Real-World Data for Evidence Generation
Session Chair(s)
Jesper Kjær, MS
Director for Public, Private Partnerships - Science, Policy & Intelligence, Novo Nordisk A/S, Denmark
This panel will discuss different types of data models that exist and their strengths and weaknesses in relation to real-world data (RWD) and interoperability.
Learning Objective : Recognize the different types of data models that exist and their strengths and weaknesses in relation to real-world data (RWD) and interoperability; Discuss the appropriate data models for primary and secondary data and how clinical data managers can potentially help RWD and trial data to meet the evidentiary requirements for regulatory decision-making.
Speaker(s)
Davera Gabriel, RN
Director of Client Success, Evidentli USA LLC, United States
Panelist
Jonathan Chainey
Executive Director, Global Head, Data Standards and Governance, Data Sciences, Roche, United States
Panelist
Stacy Tegan
Program Director, Transcelerate Biopharma Inc., United States
Panelist
Have an account?